AOL Money & Finance

Analyst upgrades, downgrades and initiations: BIOS, DISH, FTE, HBC, MDSO, TLB ...

More

Analyst upgrades:

  • FBR Capital upgraded Talbots (NYSE: TLB) to Outperform from Market Perform as it believes the company's inventory and SG&A control should help earnings and the stock's risk/reward is compelling at current levels. The firm raised its target on shares to $7 from $5.
  • ThinkEquity upgraded Human Genome (NASDAQ: HGSI) to Buy from Accumulate to reflect higher assumptions for the company's Lupus treatment Benlysta. The firm raised its target on shares to $26 from $18.
  • KeyBanc upgraded Parkway Properties (NYSE: PKY) to Buy from Hold based on valuation, improving fundamentals, and stable capital position. The firm has a $17 target on the stock.
  • HSBC Holdings (NYSE: HBC) was upgraded to Overweight from Neutral at JPMorgan.
  • BioScrip (NASDAQ: BIOS) was upgraded to Overweight from Neutral at Piper Jaffray.
  • DISH Network (NASDAQ: DISH) was upgraded to Outperform from Neutral at Credit Suisse.

Analyst downgrades:

  • Citigroup downgraded Extra Space Storage (NYSE: EXR) to Hold from Buy on concerns of declining fundamentals following the company's weaker than expected Q2 results. Citi raised its target on shares to $8.50 from $8.
  • Jefferies downgraded Savient Pharmaceuticals (NASDAQ: SVNT) to Underperform from Hold as it believes the risk/reward on shares is unfavorable given uncertainties surrounding the timing of final approval for KRYSTEXXA. The firm has a $5 price target on the stock.
  • Janney Montgomery downgraded Patriot Capital Funding (NASDAQ: PCAP) to Sell from Neutral after the company entered an acquisition agreement with Prospect Capital (NASDAQ: PSEC).
  • France Telecom (NYSE: FTE) was downgraded to Neutral from Buy at BofA/Merrill.
  • Aixtron (NASDAQ: AIXG) was downgraded to Neutral from Outperform at Credit Suisse.
  • PharMerica (NYSE: PMC) was downgraded to Perform from Outperform at Oppenheimer.

Analyst initiations:

  • Quiksilver (NYSE: ZQK) was reinstated with a Market Weight rating and $2.50 target at Thomas Weisel.
  • Phase Forward (NASDAQ: PFWD) was initiated with a Hold rating and $16 target at Citigroup.
  • Medidata Solutions (NASDAQ: MDSO) was initiated with an Outperform rating and $23 target at Credit Suisse, with a Buy rating and $22 target at Needham, and with a Hold rating and $21 target at Citigroup.
  • Myriad Genetics (NASDAQ: MYGN) was initiated with an Outperform rating at William Blair.
  • Air Products (NYSE: APD) was initiated with a Neutral rating and $86 target at Baird.
  • Targacept (NASDAQ: TRGT) was initiated with a Buy rating at Ladenburg.
Symbol Lookup
IndexesChangePrice
DJIA-14.2810,318.16
NASDAQ-10.782,146.04
S&P 500-3.521,091.38

Last updated: November 22, 2009: 11:07 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines